Literature DB >> 19445528

NMR-based metabolic profiling identifies biomarkers of liver regeneration following partial hepatectomy in the rat.

Mary E Bollard1, Nancy R Contel, Timothy M D Ebbels, Leon Smith, Olaf Beckonert, Glenn H Cantor, Lois Lehman-McKeeman, Elaine C Holmes, John C Lindon, Jeremy K Nicholson, Hector C Keun.   

Abstract

Tissue injury and repair are often overlapping consequences of disease or toxic exposure, but are not often considered as distinct processes in molecular studies. To establish the systemic metabolic response to liver regeneration, the partial hepatectomy (PH) model has been studied in the rat by an integrated metabonomics strategy, utilizing (1)H NMR spectroscopy of urine, liver and serum. Male Sprague-Dawley rats were subjected to either surgical removal of approximately two-thirds of the liver, sham operated (SO) surgery, or no treatment (n = 10/group) and samples collected over a 7 day period. A number of urinary metabolic perturbations were observed in PH rats compared with SO and control animals, including elevated levels of taurine, hypotaurine, creatine, guanidinoacetic acid, betaine, dimethylglycine and bile acids. Serum betaine and creatine were also elevated after PH, while levels of triglyceride were reduced. In the liver, triglycerides, cholesterol, alanine and betaine were elevated after PH, while choline and its derivatives were reduced. Upon examining the dynamic pattern of urinary response (the 'metabolic trajectory'), several metabolites could be categorized into groups likely to reflect perturbations to different processes such as dietary intake or hepatic 1-carbon metabolism. Several of the urinary perturbations observed during the regenerative phase of the PH model have also been observed after exposure to liver toxins, indicating that hepatic regeneration may make a contribution to the systemic alterations in metabolism associated with hepatotoxicity. The observed changes in 1-carbon and lipid metabolism are consistent with the proposed role of these pathways in the activation of a regenerative response and provide further evidence regarding the utility of urinary NMR profiles in the detection of liver-specific pathology. Biofluid (1)H NMR-based metabolic profiling provides new insight into the role of metabolism of liver regeneration, and suggests putative biomarkers for the noninvasive monitoring of the regeneration process.

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 19445528     DOI: 10.1021/pr900200v

Source DB:  PubMed          Journal:  J Proteome Res        ISSN: 1535-3893            Impact factor:   4.466


  15 in total

1.  High-resolution magic-angle-spinning NMR spectroscopy for metabolic profiling of intact tissues.

Authors:  Olaf Beckonert; Muireann Coen; Hector C Keun; Yulan Wang; Timothy M D Ebbels; Elaine Holmes; John C Lindon; Jeremy K Nicholson
Journal:  Nat Protoc       Date:  2010-05-13       Impact factor: 13.491

2.  A combined NMR- and HPLC-MS/MS-based metabolomics to evaluate the metabolic perturbations and subacute toxic effects of endosulfan on mice.

Authors:  Ping Zhang; Wentao Zhu; Dezhen Wang; Jin Yan; Yao Wang; Zhiqiang Zhou; Lin He
Journal:  Environ Sci Pollut Res Int       Date:  2017-06-26       Impact factor: 4.223

3.  Impaired liver regeneration in Ldlr-/- mice is associated with an altered hepatic profile of cytokines, growth factors, and lipids.

Authors:  Montse Pauta; Noemi Rotllan; Frances Vales; Ana Fernandez-Hernando; Ryan M Allen; David A Ford; Montserrat Marí; Wladimiro Jiménez; Angel Baldán; Manuel Morales-Ruiz; Carlos Fernández-Hernando
Journal:  J Hepatol       Date:  2013-05-24       Impact factor: 25.083

Review 4.  Review: toxicometabolomics.

Authors:  Mounir Bouhifd; Thomas Hartung; Helena T Hogberg; Andre Kleensang; Liang Zhao
Journal:  J Appl Toxicol       Date:  2013-05-30       Impact factor: 3.446

5.  Identification of transcriptional and metabolic programs related to mammalian cell size.

Authors:  Teemu P Miettinen; Heli K J Pessa; Matias J Caldez; Tobias Fuhrer; M Kasim Diril; Uwe Sauer; Philipp Kaldis; Mikael Björklund
Journal:  Curr Biol       Date:  2014-03-06       Impact factor: 10.834

6.  Enantioselective Effects of Metalaxyl Enantiomers on Breast Cancer Cells Metabolic Profiling Using HPLC-QTOF-Based Metabolomics.

Authors:  Ping Zhang; Wentao Zhu; Dezhen Wang; Jin Yan; Yao Wang; Lin He
Journal:  Int J Mol Sci       Date:  2017-01-12       Impact factor: 5.923

7.  Urinary Metabotyping of Hepatocellular Carcinoma in a UK Cohort Using Proton Nuclear Magnetic Resonance Spectroscopy.

Authors:  Mohamed I F Shariff; Jin U Kim; Nimzing G Ladep; Mary M E Crossey; Larry K Koomson; Abigail Zabron; Helen Reeves; Matthew Cramp; Stephen Ryder; Shaun Greer; I Jane Cox; Roger Williams; Elaine Holmes; Kathryn Nash; Simon D Taylor-Robinson
Journal:  J Clin Exp Hepatol       Date:  2016-04-20

8.  Urinary nuclear magnetic resonance spectroscopy of a Bangladeshi cohort with hepatitis-B hepatocellular carcinoma: A biomarker corroboration study.

Authors:  I Jane Cox; Abil E Aliev; Mary Me Crossey; Mahvish Dawood; Mamun Al-Mahtab; Sheikh M Akbar; Salimur Rahman; Antonio Riva; Roger Williams; Simon D Taylor-Robinson
Journal:  World J Gastroenterol       Date:  2016-04-28       Impact factor: 5.742

9.  Statistical HOmogeneous Cluster SpectroscopY (SHOCSY): an optimized statistical approach for clustering of ¹H NMR spectral data to reduce interference and enhance robust biomarkers selection.

Authors:  Xin Zou; Elaine Holmes; Jeremy K Nicholson; Ruey Leng Loo
Journal:  Anal Chem       Date:  2014-05-13       Impact factor: 6.986

10.  Multivariate metabotyping of plasma predicts survival in patients with decompensated cirrhosis.

Authors:  Mark J W McPhail; Debbie L Shawcross; Matthew R Lewis; Iona Coltart; Elizabeth J Want; Charalambos G Antoniades; Kiril Veselkov; Evangelos Triantafyllou; Vishal Patel; Oltin Pop; Maria Gomez-Romero; Michael Kyriakides; Rabiya Zia; Robin D Abeles; Mary M E Crossey; Wayel Jassem; John O'Grady; Nigel Heaton; Georg Auzinger; William Bernal; Alberto Quaglia; Muireann Coen; Jeremy K Nicholson; Julia A Wendon; Elaine Holmes; Simon D Taylor-Robinson
Journal:  J Hepatol       Date:  2016-01-18       Impact factor: 25.083

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.